The biggest misconception of all is also the most harmful.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as Ozempic or Wegovy, have revolutionized type 2 diabetes and ...
HealthDay News — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is common people with eating disorders, according to a research letter published online June 24 in JAMA Psychiatry.
Teen eating disorders have never been this rampant — or this severe. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content. Hospitalizations for eating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results